Bayesian Capital Management »

Structure Therapeutics shares owned by Bayesian Capital Management

Quarter-by-quarter ownership of Structure Therapeutics (GPCR) shares owned by Bayesian Capital Management from 13F filings

Historical chart of Bayesian Capital Management investment in Structure Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Structure Therapeutics held by Bayesian Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Structure Therapeutics by Bayesian Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $248k 6.1k 40.76